APA (7th ed.) Citation

KA, T., CC, E., PW, K., KG, D., A, W., 3rd, L. C., . . . MD, T. (2026). A phase Ib/II single-arm study of cabozantinib plus dostarlimab in women with recurrent gynecologic carcinosarcoma. Gynecologic oncology, 209, 107. https://doi.org/10.1016/j.ygyno.2026.05.003

Chicago Style (17th ed.) Citation

KA, Turner, Edwards CC, Ketch PW, Dinkins KG, Wilbanks A, Leath CA 3rd, Arend RC, and Toboni MD. "A Phase Ib/II Single-arm Study of Cabozantinib Plus Dostarlimab in Women with Recurrent Gynecologic Carcinosarcoma." Gynecologic Oncology 209 (2026): 107. https://doi.org/10.1016/j.ygyno.2026.05.003.

MLA (9th ed.) Citation

KA, Turner, et al. "A Phase Ib/II Single-arm Study of Cabozantinib Plus Dostarlimab in Women with Recurrent Gynecologic Carcinosarcoma." Gynecologic Oncology, vol. 209, 2026, p. 107, https://doi.org/10.1016/j.ygyno.2026.05.003.